| Research Article |
View full article
September 14, 2018
|Vol. 4, Issue 2|
The Study of Ductal Carcinoma In Situ (DCIS) with Microinvasion Using Myoepithelial Markers
Sana Firdous, Anjaneyulu, Daphne Fonseca, Sudha Murthy, Sundaram Challa and CK Naidu
Corresponding author: Dr. Sana Firdous, Resident, Basavatarakam Indo American and Cancer Institute, Sayanna Residency, Flat no.301, Krishna Nagar Colony, Opposite Gandhi Hospital, Hyderabad, Telangana, India, Tel: 00918686922063.
DCIS is a premalignant condition characterized by proliferation of neoplastic cells within the ducts with intact myoepithelial cell layer and when there is a breach in myoepithelial cell layer it indicates invasion and in both these condition treatment protocols and prognosis is different. Myoepithelial markers can be used to identify breach and hence invasion.
Citation: Firdous S, Anjaneyulu, Fonseca D, Murthy S, Challa S, et al. (2018) The Study of Ductal Carcinoma In Situ (DCIS) with Microinvasion Using Myoepithelial Markers. Int J Pathol Clin Res 4:074.